hippuric acid has been researched along with Lipidoses in 1 studies
hippuric acid: RN given refers to parent cpd; structure in Merck Index, 9th ed, #4591
N-benzoylglycine : An N-acylglycine in which the acyl group is specified as benzoyl.
Lipidoses: Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Drug-induced phospholipidosis is one of the significant concerns in drug development, especially in safety assessment and noninvasive diagnostic tool is highly desirable." | 1.46 | Biomarker discovery for drug-induced phospholipidosis: phenylacetylglycine to hippuric acid ratio in urine and plasma as potential markers. ( Higaki, K; Horinouchi, A; Kamiguchi, H; Mori, I; Murabayashi, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamiguchi, H | 1 |
| Murabayashi, M | 1 |
| Mori, I | 1 |
| Horinouchi, A | 1 |
| Higaki, K | 1 |
1 other study available for hippuric acid and Lipidoses
| Article | Year |
|---|---|
Biomarker discovery for drug-induced phospholipidosis: phenylacetylglycine to hippuric acid ratio in urine and plasma as potential markers.
Topics: Animals; Biomarkers; Drug Monitoring; Glycine; Hippurates; Lipidoses; Metabolomics; Phospholipids; R | 2017 |